Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency results in Lesch-Nyhan disease (LND), where affected individuals exhibit a characteristic neurobehavioral disorder that has been linked with dysfunction of dopaminergic pathways of the basal ganglia. Since the functions of HPRT, a housekeeping enzyme responsible for recycling purines, have no direct relationships with the dopaminergic pathways, the mechanisms whereby HPRT deficiency affect them remain unknown. The current studies demonstrate that HPRT deficiency influences early developmental processes controlling the dopaminergic phenotype, using several different cell models for HPRT deficiency. Microarray methods and quantitative PCR were applied to 10 different HPRT-deficient (HPRT -) sublines derived from the MN9D cell line. Despite the variation inherent in such mutant sublines, several consistent abnormalities were evident. Most notable were increases in the mRNAs for engrailed 1 and 2, transcription factors known to play a key role in the specification and survival of dopamine neurons. The increases in mRNAs were accompanied by increases in engrailed proteins, and restoration of HPRT reverted engrailed expression towards normal levels, demonstrating a functional relationship between HPRT and engrailed. The functional relevance of the abnormal developmental molecular signature of the HPRT -MN9D cells was evident in impoverished neurite outgrowth when the cells were forced to differentiate chemically. To verify that these abnormalities were not idiosyncratic to the MN9D line, HPRTsublines from the SK-N-BE(2) M17 human neuroblastoma line were evaluated and an increased expression of engrailed mRNAs was also seen. Over-expression of engraileds occurred even in primary fibroblasts from patients with LND in a manner that suggested a correlation with disease severity. These results provide novel evidence that HPRT deficiency may affect dopaminergic neurons by influencing early developmental mechanisms. by guest on May 2, 2016 http://hmg.oxfordjournals.org/ Downloaded from by guest on May 2, 2016 http://hmg.oxfordjournals.org/ Downloaded from
Introduction
Hypoxanthine-guanine phosphoribosyltransferase (HPRT) is a housekeeping enzyme responsible for recycling purines (1) . It converts the free purine bases, hypoxanthine and guanine, into utilizable purine nucleotides. It is expressed widely in most organisms from bacteria through mammals. In mammals, it is expressed in virtually all cells throughout development, beginning at the early blastocyst stage.
Despite nearly ubiquitous expression of HPRT, the consequences of HPRT deficiency in humans predominate in the nervous system. HPRT deficiency is an inborn error of purine metabolism, known as Lesch-Nyhan disease (LND), leading to peculiar neurological and behavioral abnormalities that include compulsive self-injurious behavior, dystonia, and cognitive disability (2) (3) (4) . The neurobehavioral phenotype has been linked with dysfunction of the basal ganglia, and particularly its dopaminergic pathways (5) (6) (7) (8) . HPRT deficiency is associated with a marked loss of basal ganglia dopamine and dopamine-related enzymes in human autopsy and imaging studies (9) (10) (11) (12) , and even in HPRT-deficient (HPRT -) mice (13) (14) (15) . The defects are relatively selective for basal ganglia dopamine pathways. Other brain dopamine pathways are largely spared, and most other neurotransmitter systems are unaffected.
The exact influence of HPRT deficiency on basal ganglia dopamine pathways is unknown, since these pathways have no obvious connection with the known biochemical functions of HPRT. Early speculations that these neural pathways might be particularly dependent upon HPRT because of unusually high levels of enzyme expression were not supported by subsequent studies (16, 17) . Another early proposal was that the metabolic consequences of HPRT deficiency resulted in degeneration or dysgenesis of dopamine neurons (8, 9) . This proposal has been undermined by results from both animal and human studies showing the marked loss of dopamine is unaccompanied by any measurable change in the numbers and morphology of dopamine neurons (14, 18) . It also has been suggested that the metabolic consequences of HPRT deficiency by guest on http://hmg.oxfordjournals.org/ Downloaded from may lead to secondary metabolic defects including oxidative stress or limitation of tetrahydrobiopterin, a cofactor essential for dopamine synthesis. These hypotheses have been refuted too (19) (20) (21) . The link between HPRT deficiency and dopamine dysfunction therefore remains enigmatic.
Tissue culture models provide powerful tools for exploring pathogenesis in many human diseases (22) . They can be exploited to probe the molecular and cellular consequences of specific genetic alterations in a tightly controlled experimental environment. Recent studies with HPRTsublines of dopaminergic mouse MN9D neuroblastoma showed that HPRT deficiency is associated with a cell-intrinsic loss of dopamine without morphological defects or signs of impaired viability (23) . The mutant cells exhibited accompanying abnormalities of nearly all biochemical markers of the dopaminergic phenotype including dopamine metabolites, enzymes involved in synthesis and degradation, and the dopamine transporter.
A novel hypothesis to account for the broad change in the biochemical signature of the dopaminergic phenotype of these cells, with no defect in structure or viability, is that HPRT deficiency influences the developmental programs that regulate their neurochemical phenotype.
This hypothesis was explored in the current studies. 
Results
Microarray analysis of HPRT-deficient MN9D cells. As a group, the HPRTsublines displayed a significant reduction in the expression of Hprt mRNA (Table 1) . This result was confirmed by qPCR and is consistent with the loss of functional HPRT enzyme activity in these cells (23) . The microarray analysis also revealed the HPRT -MN9D sublines to have significantly reduced expression of the mRNA encoding tyrosine hydroxylase (Th). The reduction in Th also was confirmed by qPCR and is consistent with prior studies showing dysregulation of multiple biochemical markers of the dopamine phenotype, including Th (23) .
In addition to abnormalities for Hprt and Th that were anticipated from prior studies, the microarray analysis revealed significant changes in several additional mRNAs ( Table 1 ). The majority (21 of 24) of abnormalities detected via microarray were confirmed by qPCR. Two were not further studied because they could not be detected by qPCR and one gave a contradictory result. A large proportion of the changes involved mRNAs encoding transcription factors known to be involved in neuronal development and differentiation. The largest quantitative change was a 19-fold increase in mRNA transcripts associated with the gene encoding engrailed 1 (En1). The homeobox A5 (HoxA5), Jund1, and paired box gene 5 (Pax5) also were increased. Other transcription factors involved in development such as the dlx gene family were not altered. These results provide support for the hypothesis that the abnormal dopaminergic phenotype of the HPRT -MN9D cells may be due to dysregulation of mechanisms that control early development and differentiation.
Developmental markers in HPRT-deficient MN9D cells. To further address the hypothesis
relating HPRT deficiency to a defect in developmental programming in the HPRT -MN9D cells, we performed a more extensive qPCR survey of additional molecular markers known to be involved in dopamine neuron differentiation. Of the 29 developmental mRNAs evaluated, more by guest on May 2, 2016 http://hmg.oxfordjournals.org/ Downloaded from than half were significantly altered. Among these, 12 mRNAs were significantly increased, 3 were significantly decreased (Table 2) , and 2 showed changes of borderline statistical significance ( Table 3 ). The largest quantitative changes included an 18-fold increase in En1 mRNA, and a 26-fold increase in mRNA transcripts associated with the gene encoding the closely related transcription factor, engrailed 2 (En2). Only 12 of 29 developmental mRNAS were not significantly affected. While more than half of the developmental markers were expressed at abnormal levels, multiple control markers evaluated by microarray and/or qPCR were normal: beta-actin, Adsl, Adk.1, App, Aprt, Akt1, Calbindin-D9K, Eefla1.1, Elk1, Elk2,
These qPCR results provide further evidence for a disruption of developmental mechanisms in the HPRT -MN9D cells.
Engrailed mRNA and protein in HPRT-deficient MN9D cells.
We focused further studies on engrailed 1 and engrailed 2 since these showed the largest quantitative changes in both the microarray and qPCR studies. To determine if the increased mRNA levels were accompanied by increased protein levels, we performed immunoblots using the polyclonal 86/8 antiserum, which recognizes both engrailed protein products (24) .
A band corresponding to the expected molecular weight of 54 KD for engrailed 1 was evident in 4 of the 10 HPRT -MN9D sublines (AG6, AG8, TG2, and TG3), yet only faintly visible in the parental MN9D line ( Figure 1 ). The bands visible on immunoblots always corresponded to sublines with increased mRNA by qPCR. Even after over-exposure of the immunoblots, a similar band of increased intensity at 54 KD could not be demonstrated for 6 of the HPRTsublines (AG2, AG5, AG10, TG4, and TG5). The absence of a visible band on immunoblots for the TG5 subline corresponded to a lack of increased mRNA in this subline by guest on May 2, 2016 http://hmg.oxfordjournals.org/ Downloaded from (Table 2) . However, the other 4 sublines exhibited a disparity between their immunoblot band intensity and their mRNA levels. Further, the most intense band on immunoblots was seen for the TG2 subline, yet highest mRNA levels were found in subline AG6. These results suggested the correlation between band intensity on immunoblots and qPCR results was not absolute. The absence of a strict correlation between the immunoblot results and qPCR could not be explained by variations in immunoblot protein loading since the same amount of protein was added in all lanes, re-probing the same blots with an antibody to beta-actin led to roughly equal band intensities, and similar results for all the sublines were obtained in 3 independently prepared immunoblots. These results confirm that elevated mRNA encoding engrailed 1 can be detected at the protein level in the HPRTsublines. However, the lack of tight correlation between the immunoblot and qPCR results implied additional variations in the efficiency of engrailed 1 protein translation or post-translational processing among some sublines.
The immunoblots also revealed a band corresponding to the expected molecular weight of 45 KD for engrailed 2 in all HPRT -MN9D sublines ( Figure 1 ). This band was relatively faint in samples from 2 of the HPRT -MN9D sublines (AG2 and TG5), and from the parental MN9D line.
Similar to the results for engrailed 1, there was only a rough correlation between the band intensity on immunoblot and the qPCR results for En2. For example, the strongest bands on immunoblots were always associated with sublines expressing elevated levels of mRNA (AG5, AG6, AG8, AG10, and TG3). Conversely, a weak band on immunoblots for AG2 corresponded to low mRNA levels ( Table 2 ). However, the TG2 subline had only a modest band on immunoblots yet the highest mRNA levels among all the sublines. The TG5 subline also was unusual with high mRNA levels, a weak immunoblot band signal at the expected molecular weight, but two moderately strong bands at slightly lower molecular weights. These smaller bands were also evident in some of the other subclones, most notably AG10. There were no apparent correlations between the intensities of the bands at 54 KD for engrailed 1 and at 45 KD 8 for engrailed 2. These results confirm that the elevated mRNA for En2 also could be detected at the protein level in the HPRTsublines, together with additional evidence or variations in engrailed 2 protein translation or post-translational processing among the sublines.
Restoration of HPRT reverses engrailed over-expression in MN9D cells.
To establish a causal relationship between HPRT deficiency and changes in engrailed mRNAs, we tested whether restoring HPRT expression would reverse the over-expression of engrailed 1 or engrailed 2. Five of the HPRT -MN9D sublines exhibiting robust over-expression of mRNAs encoding En1 or En2 (AG6, AG8, AG10, TG2, TG3) were transfected with a minigene in which human HPRT was driven by the chicken beta-actin promoter and selected for functional expression of HPRT enzyme in HAT medium. Using species-specific primers for HPRT, 4 of the HAT-resistant lines were determined to be transfectants expressing human HPRT mRNA and 1 appeared to be a spontaneous revertant expressing mouse HPRT mRNA (AG8).
The restoration of HPRT activity was confirmed by enzymatic assay. The parent MN9D line had readily detectable HPRT enzyme activity, and all 5 HPRT -MN9D sublines had enzyme levels at or below levels of detection (Table 4 ). After the transfection procedure and selection in HAT medium, HPRT enzyme activity was restored in all 5 sublines, with levels ranging from 55- The numbers of neurites per cell were markedly reduced, and neurites were short and simple.
These results provide morphological evidence that HPRT deficiency influences developmental processes in the MN9D cell line.
Over-expression of engrailed in other HPRT-deficient cells. To determine if over-expression of
En1 or En2 might be an idiosyncratic effect of HPRT deficiency limited to MN9D cells, we also examined 4 HPRTsublines of the M17 human neuroblastoma line (22) by qPCR. In comparison to the HPRT-competent parent M17 line, En1 mRNA was increased in 3 of the HPRT -M17 sublines, with levels as high as 15-fold above controls. En2 mRNA was increased in only 1 of the lines, by more than 5-fold ( Figure 4 ). Control mRNAs were expressed at normal levels including beta-actin, Gapdh, Myl6. These results revealed that over-expression of the engrailed transcription factors is not limited to HPRTmouse MN9D cells, but also can be observed in HPRThuman M17 neuroblastoma cells.
To determine if the over-expression of En1 or En2 might be a more general property of HPRT deficiency even in non-neural cells, we examined primary skin fibroblasts obtained from 8 patients with HPRT deficiency. Half of these fibroblasts came from patients with the classic Lesch-Nyhan phenotype (LND) with hyperuricemia and severe neurobehavioral dysfunction, while half came from Lesch-Nyhan variants (LNV) with hyperuricemia but little or no neurobehavioral dysfunction. Fibroblasts from 4 patients with unrelated neurobehavioral disorders served as controls. Measurable levels of En1 mRNA were found in all fibroblast samples ( Figure 5 ). Though there was considerable overlap in the levels among patients with HPRT deficiency and controls, there was a population trend that suggested a correlation between En1 mRNA level and disease severity, with a statistically significant difference between controls and those with the classic LND phenotype (p<0.02).
All fibroblasts also expressed En2 mRNA. The 4 mildly affected Lesch-Nyhan variants had levels indistinguishable from controls. However, En2 was increased in the fibroblasts from patients who had neurobehavioral manifestations typical of the classic LND form. These samples showed no overlap with controls, with an average increase more than 3-fold controls (p<0.05).
These results revealed that over-expression of En2 occurred even in HPRThuman primary fibroblasts, in a manner that suggested a correlation with the manifestation of neurobehavioral dysfunction. While En1 or En2 were increased in the HPRTfibroblasts, multiple control mRNAs were expressed at normal levels including Aprt, Adsl, Myl6, Prps1, Prps2, and Comt (not shown).
Discussion
A serious challenge in elucidating the pathogenesis of human HPRT deficiency is its rarity, with so few patients or patient-derived materials available for experimental investigations. A further challenge in elucidating the mechanisms responsible for the neurological abnormalities is the relative inaccessibility of relevant brain pathways to experimental investigations. In view of these challenges, surrogate experimental models have been used for exploring pathogenesis. In the current studies, we took advantage of multiple independent cell models for HPRT deficiency. Another limitation of cell models is that findings may be idiosyncratic to the cell model studied, with no relevance to other experimental models. This limitation was addressed by evaluating HPRTcell models from multiple different sources. In addition to the 10 HPRT -MN9D sublines, we examined 4 HPRTsublines of human M17 neuroblastoma. All 4 of the mutant M17 sublines exhibited an increase in En1 expression, while En2 expression was more variable. We also evaluated primary human fibroblasts from 8 patients with varying degrees of HPRT deficiency. There was again evidence for increased expression of En1 and/or En2 in the HPRTfibroblasts relative to controls. Thus increased expression of one or both engrailed genes appears to be common to several cell models of HPRT deficiency, including those derived from affected patients. The final limitation of cell models is that the findings may be restricted to the in vitro environment, with little relevance for the in vivo state, especially in the brain. This limitation can be addressed only by examining brain tissue from affected Lesch-Nyhan patients. Because the developmental markers in question have specific temporal windows of expression, it may be necessary to study these brains at various stages of development. Though such studies are not feasible because of the absence of appropriate human brain specimens, it is important to note that the hypothesis regarding a defect in developmental programming of the dopamine neurochemical phenotype is consistent with prior human studies showing a relatively broad disruption of many biochemical markers of the dopamine phenotype (7, 9, 10, 26) with no apparent histological evidence for loss of cells or axonal projections (2, 10, 27) .
A disruption of molecular pathways that control early development provides a novel mechanism that could account for the well-known association between HPRT deficiency and dysfunction of brain dopamine systems. The En1 and En2 genes encode two closely related transcription factors that are part of a large family of homeobox transcription factors responsible for many developmental processes. The engrailed products have specific roles in two events during neural development. Early in embryogenesis, they take part in establishing the size and region of the midbrain in which dopamine neurons later develop. Later they play a role in the specification and survival of dopamine neurons (28) (29) (30) . They function as nuclear transcription factors that alter the expression of multiple other genes, but they also can be released from cells and internalized by neighbors, where they are thought to exert paracrine-like activities (31, 32) .
The genes have partly overlapping functions, such that one can partly compensate for loss of the other (33) . In mutant mice homozygous for null mutations in both genes, dopamine neurons are generated between embryonic days 11 and 14, but the entire population disappears before birth and the pups cannot survive (28, 29) . Intermediate genotypes with one or more copies of either gene display varying degrees of midbrain dopamine neuron loss (24, 34) . In our HPRT -MN9D sublines, there were no apparent correlations between expression of En1 and En2 among the HPRTcells. Some HPRTcells exhibited an increase in both engrailed genes, while others exhibited increases in only one. The lack of consistent increases in both mRNA and protein products may be related to the redundant biological functions of these two homeoproteins.
There is good evidence that alterations in the expression of the engrailed genes influence dopamine neuron development and survival. Transcription factors of the homeoprotein family present cell autonomous and non-cell autonomous activities that can influence neurite elongation and guidance. In the case of engrailed, several of its putative transcriptional targets may play such a function. Among the latter targets are EphrinA5, a cell surface protein with collapsing activity (35) and MAP1B a microtubule associated protein that regulates microtubule polymerization in the axon (36). More recently it was shown that engrailed serves as an axon guidance factor, in a non-cell autonomous way, by regulating mRNA translation within the growth cones (37) . It is also of interest that engrailed-1 is present in the dendrites of midbrain dopaminergic neurons (38) .
Although the latter localization is in want of a function, the ability of engrailed to regulate translation in developing axons, leaves open the possibility that a similar mechanism is used to regulate dendrite geometry. Thus the morphological defects seen in our differentiated HPRT -MN9D cells might represent downstream consequences of abnormal expression of the engraileds.
The mechanisms by which HPRT deficiency influences the expression of the engrailed genes remain to be determined. One possibility is that engrailed expression may be affected directly by HPRT. While there currently is no evidence that HPRT can affect the engrailed or other developmental pathways directly, there is ample precedent for other housekeeping enzymes having such additional "moonlighting" activities in addition to their traditionally ascribed functions (39) (40) (41) . Thus HPRT may have a moonlighting function beyond its role in purine recycling. Alternatively, HPRT deficiency may influence engrailed pathways indirectly, through the secondary changes in purine metabolism that occur when HPRT is missing. Indeed, disruption by guest on May 2, 2016 http://hmg.oxfordjournals.org/ Downloaded from of purine levels is known to have an important influence on neuronal differentiation in other cells (42, 43) . It also is possible that over-expression of engrailed genes reflects a compensatory developmental response to a defect elsewhere in the developmental programs of these neurons.
Whether the effect is direct or indirect, the implication of the current findings is that HPRTmediated purine recycling, has an important role in regulating early developmental programming of dopaminergic neurons. Further studies will be required to more completely delineate the complex cascade of events resulting from HPRT deficiency and their influence on brain development. 
Materials and Methods
Cell cultures. The initial studies were conducted with the MN9D cell line, which is a hybrid line derived through the somatic fusion of primary midbrain dopaminergic neurons from an embryonic day 14 mouse with the mouse neuroblastoma line N18TG2 (44). A total of 10 spontaneously arising HPRT -MN9D sublines were isolated by selection in 6-thioguanine or 8azaguanine (23) . These cells were grown routinely at 37°C under 5% CO 2 and 95% air in DMEM (Sigma, St. Louis, MO) supplemented with 15% fetal bovine serum, 100 U/ml penicillin, and 50 mg/ml streptomycin. For some studies, the cells were differentiated with sodium butyrate as previously described (25) .
Confirmatory studies were conducted with the SK-N-BE(2) M17 line (M17), a human dopaminergic neuroblastoma of peripheral origin (ATCC, Manassas, VA, USA). Instead of selecting spontaneously arising mutants as in the case of the MN9D line, HPRT -M17 sublines were prepared by targeting a psoralen cross-link to a site immediately adjacent to exon 5 with a triple helix-forming oligonucleotide followed by selection in 6-thioguanine (22) . These cells were cultured at 37°C with 5% CO2 in RPMI 1640 media supplemented with 15% fetal bovine serum and 2 mM L-glutamine.
Additional studies were conducted with primary cell lines from affected patients and controls. Primary human male fibroblast cultures were available from a tissue bank for 4 patients who had the full classic phenotype of LND, 4 mildly affected LND variants in whom some of the clinical features were absent or attenuated, and 4 controls without HPRT deficiency. Fibroblast cultures were prepared following full thickness skin biopsy. Tissue was minced aseptically in phosphate buffered saline free of Ca 2+ and Mg 2+ , then incubated with gentle agitation at 37º C for 1 hr in a sterile collagenase/dipase solution at 1 mg/ml (Roche Diagnostics, Mannheim, Germany). The partially digested material was pelleted at 1,000 x g, then resuspended in DMEM with 20% fetal bovine serum supplemented with 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml by guest on May 2, 2016 http://hmg.oxfordjournals.org/ Downloaded from streptomycin, and 2.5 µg/ml amphotericin B. The suspension was plated in a 10 cm plate and fibroblasts were allowed to attach and grow out undisturbed for a few days. Cells were split when they reached confluence and maintained in DMEM with 10% fetal bovine serum supplemented with 2 mM glutamine thereafter. HPRT and APRT enzyme activities. These enzymes were measured as previously described (47, 48). Briefly, cells were grown to ~90% confluency in a T75 culture flask, dislodged by trypsinization, and pelleted by centrifugation at 1,000 x g for 5 min. Pelleted cells were then frozen and stored at -80°C until assayed. Enzyme activities were assessed in total soluble extracts of cellular lysates by using [ 14 C]-hypoxanthine or [ 14 C]-adenine followed by separation of substrate and product by chromatography. Activity was normalized to total protein quantified in the lysate by the Lowry method. was added, the sample was shaken vigorously for 20 sec, and incubated at 4°C for 5 min. The sample was centrifuged at 10,000 x g for 15 min at 4°C. An aliquot of 500 µl of the upper aqueous phase was removed and mixed with 500 µl of isopropyl alcohol. RNA was allowed to precipitate overnight at -20°C. The next day, RNA was pelleted at 10,000 x g for 10 min at 4°C and the pellet was washed twice with 1 mL of 75% ethanol and centrifuged at 5,000 x g for 5 min at 4°C. Following the second wash, the pellet was air-dried for 10 min. Total RNA was dissolved in RNAse-free water and adjusted to 1µg/µL after a spectrophotometric measure of RNA at 260 nm. The samples were stored at -80°C until further analysis. Quantitative PCR (qPCR) was performed using a LightCycler and the FastStart DNA Master PLUS SYBR Green I kit (Roche Applied Science, Mannheim, Germany) as previously described (23) . Primers were designed via Primerbank (pga.mgh.harvard.edu/primerbank).
Restoration of HPRT. An expression vector in which human
Reactions were conducted with 1 µl of each cDNA, 0.1 µL of each primer at 0.5 µM, 2 µL of 5X FastStart DNA Master SYBR Green containing the FastStart Taq DNA polymerase, MgCl 2 , the dNTP mix, and the fluorescent dye SYBR Green I. RNase-free water was added to reach the final volume of 10 µL. The pre-incubation and denaturation of the samples were performed at 95°C for 10 min. This was followed by amplification of the target cDNA through 45 cycles at 95°C for 10 sec, with annealing temperatures adapted according to the Tm of primers (primers and qPCR conditions are described in supplements 1 and 2) and elongation at 72°C for 12 sec. Finally, samples were cooled to 35°C. Each reaction was performed in quadruplicate for each sample.
Expression of Myl6, beta-actin and GAPDH was used to normalize the raw data. The qPCR for the target gene and Myl6 or beta-actin or GAPDH was performed under the same PCR conditions in the same run. Each RT qPCR assay was designed and experimentally validated to amplify a single, gene-specific amplicon of the correct size with uniform PCR efficiency and without nonspecific products. To check the specificity of each amplicon a melting curve analysis was included in each run and showed a single specific peak for each amplicon. For all amplicons tested, the melting temperature was always above 80°C, avoiding detection of primer dimers having a melting temperature at 55-60°C. The quantification was performed by the crossing point method. In order to detect differences in PCR efficiency, standard curves for each analyzed cDNA were constructed employing reverse transcribed control RNA from parental cells as calibrator.
Western blot and antibodies. Protein samples were heated for 10 min at 95°C in sample buffer (0.4M Tris-HCL pH 6.8, 0.1M DTT, 2% SDS, 8.7% glycerol), separated on a 10% SDS-PAGE gel, and transferred onto Immobilon P membranes (Millipore, Billerica MA, USA). Membranes were blocked for 1 hr at room temperature in 5% non fat milk in Tris buffered saline containing 0.2% (v/v) Tween 20 and incubated with an anti-engrailed rabbit polyclonal antibody (86.8; 1:4000) at 4°C overnight (24) . Membranes were washed 5 times for 5 min in the same buffer, incubated with horseradish peroxidase-conjugated secondary anti-rabbit antibody (1:4000) for 1 hr at room temperature and washed 5 times for 5 min. Membranes were incubated with ECL+ by guest on May 2, 2016 http://hmg.oxfordjournals.org/ Downloaded from HRP detection reagent (Amersham, Buckinghamshire, UK) and exposed to x-ray film. To verify equal loading of total protein, membranes were stripped for 30 min at 50°C in 100 mM 2mercaptoethanol and 2% sodium dodecyl sulfate in 62.5 mM Tris-HCl pH 6.7. Successful stripping was verified with the detection reagent and exposure to x-ray film for 5 min. In the absence of any remaining signal, the membrane was washed 2 times for 5 min, blocked as described above, exposed to anti-beta actin rabbit polyclonal at 1:500 dilution (sc-1616, Santa Cruz Biotechnology, Santa Cruz CA, USA) overnight at 4°C and revealed as described above.
Data analysis.
The qPCR results for each mRNA were normalized to simultaneously processed control mRNAs (beta-actin, GAPDH, and Myl 6). The final results for qPCR studies were similar for normalization with each of these control markers. Data for most qPCR experiments therefore are presented with normalization against Myl6 only, except for one experiment where a simultaneous immunoblot using an antibody to beta-actin is presented.
The statistical approach for the microarray analysis compared results for the parental MN9D cell line against all 10 HPRT -MN9D cell lines, searching for significant changes across the whole group of HPRTlines, rather than idiosyncratic changes among individual lines (23) .
The same approach was used to compare qPCR results for the control versus the HPRT -MN9D mutants. In other experiments involving fewer samples for comparisons, data were evaluated by one-way ANOVA with post-hoc Tukey t-tests. Individual means were compared via Student's ttest.
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Choi Dyes were reversed for the duplicate to reduce the effects of dye incorporation bias (Dye1 and Dye2). The only significant changes are shown in this table. ND: not detected by qPCR with two different primer pairs. 
The results for each mRNA in each cell line were determined in quadruplicate by qPCR and normalized to a simultaneously processed control mRNA (Myl6). Results from the HPRTlines are presented as percent changes relative to a simultaneously processed sample of the HPRT + parent line. The overall change reflects the aggregate results of all the HPRTlines combined. The results for all 10 HPRT -MN9D cell lines were compared as a group against the parent MN9D line by a single-sample t-test. A Bonferroni correction for the 29 simultaneous comparisons in this 
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Results show enzyme activity expressed as nmol/mg protein per min, and percent of control. Each value was determined from a kinetic assay with 5 time points. Four of the lines in which HPRT was restored were found to be transfectants expressing the human HPRT mRNA (transf), while one was found to be a spontaneous revertant expressing the mouse HPRT mRNA (revert).
